2010 publications

Schuringa JJ. Tracing C/EBP{alpha}+ cells and their progeny. Blood. 2010 Nov 18;116(20):4038-4039.

Rizo A, Horton SJ, Olthof S, Dontje B, Ausema A, van Os R, van den Boom V, Vellenga E, de Haan G, Schuringa JJ. BMI1 collaborates with BCR-ABL in leukemic transformation of human CD34+ cells. Blood. 2010 Aug 19. [Epub ahead of print]

Huls G, Mulder AB, Rosati S, van de Loosdrecht AA, Vellenga E, de Wolf JT. Efficacy of single-agent lenalidomide in patients with JAK2 (V617F) mutated refractory anemia with ring sideroblasts and thrombocytosis. Blood. 2010 Jul 15;116(2):180-2. Epub 2010 Mar 1.

Westenbrink BD, Voors AA, de Boer RA, Schuringa JJ, Klinkenberg T, van der Harst P, Vellenga E, van Veldhuisen DJ, van Gilst WH. Bone marrow dysfunction in chronic heart failure patients. Eur J Heart Fail. 2010 Jul;12(7):676-84. Epub 2010 Apr 28.

Kruyt FA, Schuringa JJ. Apoptosis and cancer stem cells: Implications for apoptosis targeted therapy. Biochem Pharmacol. 2010 Aug 15;80(4):423-30. Epub 2010 Apr 13.

Han L, Schuringa JJ, Mulder A, Vellenga E. Dasatinib impairs long-term expansion of leukemic progenitors in a subset of acute myeloid leukemia cases. Ann Hematol. 2010 Sep;89(9):861-71. Epub 2010 Apr 13.

Woolthuis C, Agool A, Olthof S, Slart RH, Huls G, Smid WM, Schuringa JJ, Vellenga E. Auto-SCT induces a phenotypic shift from CMP to GMP progenitors, reduces clonogenic potential and enhances in vitro and in vivo cycling activity defined by (18)F-FLT PET scanning. Bone Marrow Transplant. 2010 Apr 12. [Epub ahead of print]

Wierenga AT, Vellenga E, Schuringa JJ. Down-regulation of GATA1 uncouples STAT5-induced erythroid differentiation from stem/progenitor cell proliferation. Blood. 2010 Jun 3;115(22):4367-76. Epub 2010 Mar 25.

Schuringa JJ, Vellenga E. Role of the polycomb group gene BMI1 in normal and leukemic hematopoietic stem and progenitor cells. Curr Opin Hematol. 2010 Jul;17(4):294-9. Review.

Huls G, Mulder AB, Rosati S, van de Loosdrecht AA, Vellenga E, de Wolf JT. Efficacy of single-agent lenalidomide in patients with JAK2 (V617F) mutated refractory anemia with ring sideroblasts and thrombocytosis. Blood. 2010 Jul 15;116(2):180-2. Epub 2010 Mar 1.

Schaapveld M, Visser O, Siesling S, Schaar CG, Zweegman S, Vellenga E. Improved survival among younger but not among older patients with Multiple Myeloma in the Netherlands, a population-based study since 1989. Eur J Cancer. 2010 Jan;46(1):160-9. Epub .

Agool A, Slart RH, Dierckx RA, Kluin PM, Visser L, Jager PL, Vellenga E. Somatostatin receptor scintigraphy might be useful for detecting skeleton abnormalities in patients with multiple myeloma and plasmacytoma. Eur J Nucl Med Mol Imaging. 2010 Jan;37(1):124-30. Epub .